Oruka Therapeutics (ORKA) Interest Coverage Ratio (2010 - 2022)
Oruka Therapeutics (ORKA) recorded quarterly Interest Coverage Ratio of 850.67 in Q3 2022, up 48.08% quarter-over-quarter from 1638.5 in Q1 2022.
Oruka Therapeutics (ORKA) Interest Coverage Ratio (2010 - 2022) Analysis & Trends
Oruka Therapeutics' Interest Coverage Ratio history runs 11 years deep, the most recent figure standing at 850.67 for Q3 2022.
- In Q3 2022, Interest Coverage Ratio changed N/A year-over-year to 850.67; the TTM figure through Jun 2023 stood at 2623.0 (up 68.94% YoY), while the FY2022 annual figure was 2119.2, changed N/A from the prior year.
- Interest Coverage Ratio was 850.67 for Q3 2022 at Oruka Therapeutics, up from 1638.5 in the prior quarter.
- In the past five years, Interest Coverage Ratio ranged from a high of 335.0 in Q1 2020 to a low of 1638.5 in Q1 2022.
- Historically, Interest Coverage Ratio has averaged 824.83 across 4 years, with a median of 831.0 in 2018.
- The sharpest annual moves came in 2018 and 2019: Interest Coverage Ratio surged 74.14% in 2018, then tumbled 50.06% in 2019.
- A 4-year view of Interest Coverage Ratio shows it stood at 831.0 in 2018, then tumbled by 50.06% to 1247.0 in 2019, then increased by 20.21% to 995.0 in 2020, then advanced by 14.51% to 850.67 in 2022.
- The last three Interest Coverage Ratio figures came in at 850.67 (Q3 2022), 1638.5 (Q1 2022), and 995.0 (Q3 2020), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 3.58 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 11.50 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -258.33 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 547.67 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 11.79 |
| 10 | Oruka Therapeutics | 4.04 Bn | 3.65 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2022 | -850.67 |
| Mar 31, 2022 | -1,638.50 |
| Sep 30, 2020 | -995.00 |
| Jun 30, 2020 | -436.67 |
| Mar 31, 2020 | -335.00 |
| Sep 30, 2019 | -1,247.00 |
| Jun 30, 2019 | -502.67 |
| Mar 31, 2019 | -593.67 |
| Sep 30, 2018 | -831.00 |
| Jun 30, 2018 | -718.67 |
| Mar 31, 2018 | -924.33 |
| Sep 30, 2017 | -2,237.50 |
| Jun 30, 2017 | -2,779.50 |
| Mar 31, 2017 | -2,190.50 |
| Sep 30, 2015 | -2,817.00 |
| Jun 30, 2015 | -1,359.50 |
| Mar 31, 2015 | -2,744.00 |
| Sep 30, 2014 | -2,285.00 |
| Jun 30, 2014 | -2,406.00 |
| Mar 31, 2014 | -2,390.00 |